Form 13-F position report

* DOLBY LABORATORIES INC

Reported by BAILLIE GIFFORD & CO

DLB CUSIP 25659T107 Manager CIK 0001088875

Reported 503,135 shares, up 121,923 (32.0%) from the prior quarter.

Reported value 20.7%; share count 32.0% vs. the prior quarter.

Added
% of reported 13F value 0.04% This manager · Q2 2022
Shares 503,135 Quarter-end amount reported
Reported value $36,004,000 Fair value at quarter end
Consecutive quarters held 37 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 33867000
2022-03-31 29818000
2022-06-30 36004000
2022-09-30 33940000
2022-12-31 44061824
2023-03-31 58545501
2023-06-30 55976815
2023-09-30 42144840
2023-12-31 40983072
2024-03-31 38741363
2024-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

11 quarters
Quarterly reported position history for * DOLBY LABORATORIES INC held by BAILLIE GIFFORD & CO.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2024 Reduced 0 -462,473 (-100.0%) 0 $0 2024-07-25
Q1 2024 Reduced 462,473 -13,079 (-2.8%) 0.03% $38,741,363 2024-05-01
Q4 2023 Reduced 475,552 -56,177 (-10.6%) 0.03% $40,983,072 2024-01-26
Q3 2023 Reduced 531,729 -137,210 (-20.5%) 0.04% $42,144,840 2023-11-13
Q2 2023 Reduced 668,939 -16,445 (-2.4%) 0.05% $55,976,815 2023-07-28
Q1 2023 Added 685,384 +60,748 (9.7%) 0.05% $58,545,501 2023-05-03
Q4 2022 Added 624,636 +103,683 (19.9%) 0.05% $44,061,824 2023-01-24
Q3 2022 Added 520,953 +17,818 (3.5%) 0.03% $33,940,000 2022-10-27
Q2 2022 Added 503,135 +121,923 (32.0%) 0.04% $36,004,000 2022-08-08
Q1 2022 Added 381,212 +25,536 (7.2%) 0.02% $29,818,000 2022-05-05
Q4 2021 Added 355,676 +43,572 (14.0%) 0.02% $33,867,000 2022-01-20
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

385 managers reported * DOLBY LABORATORIES INC for Q2 2022.

Managers reporting * DOLBY LABORATORIES INC in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Reduced 6,191,117 -66,040 0.01% $443,037,000 37 qtrs
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC Added 4,052,837 +2,183,842 0.92% $290,021,000 9 qtrs
ATLANTA CAPITAL MANAGEMENT CO L L C Reduced 3,738,973 -9,000 1.15% $267,561,000 10 qtrs
Clearbridge Investments LLC Reduced 3,219,426 -99,188 0.21% $230,382,000 37 qtrs
BlackRock Inc Added 3,138,348 +14,502 < 0.01% $224,580,000 37 qtrs
Ninety One UK Ltd Reduced 2,662,638 -59,896 0.57% $190,538,000 4 qtrs
Jackson Square Partners LLC Reduced 2,629,576 -751,854 4.39% $188,172,000 7 qtrs
SOMA EQUITY PARTNERS LP Reduced 2,000,000 -300,000 7.57% $143,120,000 8 qtrs
THE BANK OF NEW YORK MELLON CORPORATION Reduced 1,732,557 -45,782 0.03% $123,980,000 37 qtrs
DISCIPLINED GROWTH INVESTORS INC MN Added 1,620,572 +70,265 3.12% $115,968,000 37 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 08, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
500,655
Shared
0
None
2,480

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.